Brief: Nuformix Provides Update In Relation To Company's Nxp004 Programme

Nuformix

29/06/2022 07:05

June 29 (Reuters) - Nuformix PLC  NFXN.L :
    * NUFORMIX PLC - UPDATE IN RELATION TO COMPANY'S NXP004
PROGRAMME,
FOCUSED ON DEVELOPMENT OF NOVEL PHYSICAL FORMS OF OLAPARIB
    * NUFORMIX PLC - OLAPARIB IS KNOWN TO PRESENT SIGNIFICANT
CHALLENGES IN ACHIEVING EFFECTIVE ORAL DELIVERY
    * NUFORMIX PLC - COMPANY  INITIATED PROGRAMME OF WORK TO
PROGRESS
NXP004 PROGRAMME; COMMENCE SCALE-UP OF LEAD COCRYSTAL PRODUCTION
PROCESSE

Source text for Eikon:  ID:nRSc5387Qa 
Further company coverage:  NFXN.L 

 ((Reuters.Briefs@thomsonreuters.com;))